<!DOCTYPE html>
<html lang="en-GB" xmlns:og="http://ogp.me/ns#" xmlns:fb="http://ogp.me/ns/fb#">
<head >
<meta charset="UTF-8" />
<title>COMPare -   Henry Drysdale</title>		<meta name="robots" content="noindex,noodp,noydir" />
		<meta name="viewport" content="width=device-width, initial-scale=1" />
<link rel='dns-prefetch' href='http://w.sharethis.com/' />

<link rel="alternate" type="application/rss+xml" title="COMPare &raquo; Feed" href="../../../feed/index.html" />
<link rel="alternate" type="application/rss+xml" title="COMPare &raquo; Comments Feed" href="../../../comments/feed/index.html" />
<link rel="alternate" type="application/rss+xml" title="COMPare &raquo; Posts by Henry Drysdale Feed" href="feed/index.html" />
<link rel="canonical" href="index.html" />
<link rel='stylesheet' id='parallax-pro-theme-css'  href='../../../wp-content/themes/parallax-pro/style.css%3Fver=1.2.2.css' type='text/css' media='all' />
<link rel='stylesheet' id='sm-style-css'  href='../../../wp-content/plugins/wp-show-more/wpsm-style.css%3Fver=4.6.16.css' type='text/css' media='all' />
<link rel='stylesheet' id='kamn-css-easy-twitter-feed-widget-css'  href='../../../wp-content/plugins/easy-twitter-feed-widget/easy-twitter-feed-widget.css%3Fver=4.6.16.css' type='text/css' media='all' />
<link rel='stylesheet' id='dashicons-css'  href='../../../wp-includes/css/dashicons.min.css%3Fver=4.6.16.css' type='text/css' media='all' />
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Montserrat&family=Sorts+Mill+Goudy&display=swap" rel="stylesheet">
<link rel='stylesheet' id='sccss_style-css'  href='../../../index.css' type='text/css' media='all' />
<script type='text/javascript' src='../../../wp-includes/js/jquery/jquery.js%3Fver=1.12.4'></script>
<script type='text/javascript' src='../../../wp-includes/js/jquery/jquery-migrate.min.js%3Fver=1.4.1'></script>
<script type='text/javascript'>
/* <![CDATA[ */
var cssTarget = "img.";
/* ]]> */
</script>
<script type='text/javascript' src='../../../wp-content/plugins/svg-support/js/min/svg-inline-min.js%3Fver=1.0.0'></script>
<!--[if lt IE 9]>
<script type='text/javascript' src='http://compare-trials.org/wp-content/themes/genesis/lib/js/html5shiv.min.js?ver=3.7.3'></script>
<![endif]-->
<script type='text/javascript' src='../../../wp-content/themes/parallax-pro/js/responsive-menu.js%3Fver=1.0.0'></script>
<script id='st_insights_js' type='text/javascript' src='http://w.sharethis.com/button/st_insights.js?publisher=eba0f3ba-f9ab-408c-bc68-c28af5afe749&#038;product=feather'></script>
<link rel='https://api.w.org/' href='../../../wp-json/index.html' />
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="../../../xmlrpc.php%3Frsd" />
<style type='text/css'></style>
<link rel="next" href="page/2/index.html" />

<style type="text/css"></style>

<style type="text/css">
.synved-social-resolution-single {
display: inline-block;
}
.synved-social-resolution-normal {
display: inline-block;
}
.synved-social-resolution-hidef {
display: none;
}

@media only screen and (min--moz-device-pixel-ratio: 2),
only screen and (-o-min-device-pixel-ratio: 2/1),
only screen and (-webkit-min-device-pixel-ratio: 2),
only screen and (min-device-pixel-ratio: 2),
only screen and (min-resolution: 2dppx),
only screen and (min-resolution: 192dpi) {
	.synved-social-resolution-normal {
	display: none;
	}
	.synved-social-resolution-hidef {
	display: inline-block;
	}
}
</style>
<link rel="icon" href="../../../wp-content/uploads/2016/01/cropped-original-32x32.png" sizes="32x32" />
<link rel="icon" href="../../../wp-content/uploads/2016/01/cropped-original-192x192.png" sizes="192x192" />
<link rel="apple-touch-icon-precomposed" href="../../../wp-content/uploads/2016/01/cropped-original-180x180.png" />
<meta name="msapplication-TileImage" content="http://compare-trials.org/wp-content/uploads/2016/01/cropped-original-270x270.png" />

<script async defer data-domain="compare-trials.org" src="https://plausible.io/js/plausible.js"></script>

<!-- START - Facebook Open Graph, Google+ and Twitter Card Tags 2.0.4 -->
 <!-- Facebook Open Graph -->
  <meta property="og:locale" content="en_GB"/>
  <meta property="og:site_name" content="COMPare"/>
  <meta property="og:title" content="Henry Drysdale"/>
  <meta property="og:url" content="http://compare-trials.org/blog/author/henrydrysdale/"/>
  <meta property="og:type" content="article"/>
  <meta property="og:description" content="Tracking switched outcomes in clinical trials"/>
  <meta property="og:image" content="http://compare-trials.org/wp-content/uploads/2016/01/logo_large-1.png"/>
 <!-- Google+ / Schema.org -->
  <meta itemprop="name" content="Henry Drysdale"/>
  <meta itemprop="description" content="Tracking switched outcomes in clinical trials"/>
  <meta itemprop="image" content="http://compare-trials.org/wp-content/uploads/2016/01/logo_large-1.png"/>
 <!-- Twitter Cards -->
  <meta name="twitter:title" content="Henry Drysdale"/>
  <meta name="twitter:url" content="http://compare-trials.org/blog/author/henrydrysdale/"/>
  <meta name="twitter:description" content="Tracking switched outcomes in clinical trials"/>
  <meta name="twitter:image" content="http://compare-trials.org/wp-content/uploads/2016/01/logo_large-1.png"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:site" content="@compare_trials"/>
 <!-- SEO -->
  <meta name="description" content="Tracking switched outcomes in clinical trials"/>
 <!-- Misc. tags -->
<!-- END - Facebook Open Graph, Google+ and Twitter Card Tags 2.0.4 -->

</head>
<body class="archive author author-henrydrysdale author-3 full-width-content" itemscope itemtype="http://schema.org/WebPage"><div class="site-container"><header class="site-header" itemscope itemtype="http://schema.org/WPHeader"><div class="wrap"><div class="title-area"><h1 class="site-title" itemprop="headline"><a href="../../../index.html">COMPare</a></h1><h2 class="site-description" itemprop="description">Tracking switched outcomes in clinical trials</h2></div><div class="widget-area header-widget-area"><section id="nav_menu-3" class="widget widget_nav_menu"><div class="widget-wrap"><nav class="nav-header" itemscope itemtype="http://schema.org/SiteNavigationElement"><ul id="menu-main-menu" class="menu genesis-nav-menu"><li id="menu-item-14" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-14"><a href="../../../project.html" itemprop="url"><span itemprop="name">Methods</span></a></li>
<li id="menu-item-15" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-15"><a href="../../../results.html" itemprop="url"><span itemprop="name">Results</span></a></li>
<li id="menu-item-13" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-13"><a href="../../../team.html" itemprop="url"><span itemprop="name">Team</span></a>
<ul class="sub-menu">
	<li id="menu-item-633" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-633"><a href="../../../speaking.html" itemprop="url"><span itemprop="name">SPEAKING DATES</span></a></li>
</ul>
</li>
<li id="menu-item-230" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-230"><a href="../../../faq.html" itemprop="url"><span itemprop="name">FAQ</span></a></li>
<li id="menu-item-19" class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-19"><a href="../../index.html" itemprop="url"><span itemprop="name">Blog</span></a></li>
</ul></nav></div></section>
</div></div></header><div class="site-inner"><div class="content-sidebar-wrap"><main class="content"><article class="post-599 post type-post status-publish format-standard category-uncategorized entry" itemscope itemtype="http://schema.org/CreativeWork"><header class="entry-header"><h1 class="entry-title" itemprop="headline"><a href="../../annals-update-protocol-sharing-requirements-for-trialists-after-compare-finds-shortcomings/index.html" rel="bookmark">Annals update protocol sharing requirements for trialists, after COMPare finds shortcomings</a></h1> 
<p class="entry-meta"><time class="entry-time" itemprop="datePublished" datetime="2016-05-03T13:30:46+00:00">May 3, 2016</time> - by <span class="entry-author" itemprop="author" itemscope itemtype="http://schema.org/Person"><a href="index.html" class="entry-author-link" itemprop="url" rel="author"><span class="entry-author-name" itemprop="name">Henry Drysdale</span></a></span> <span class="entry-comments-link"><a href="../../annals-update-protocol-sharing-requirements-for-trialists-after-compare-finds-shortcomings/index.html#respond">Leave a Comment</a></span></p></header><div class="entry-content" itemprop="text"><p><span style="color: #000000;">The COMPare Trials research project assessed 5 trials published in Annals of Internal Medicine for misreported outcomes &#8211; a well-documented and common source of bias. We found that <span style="color: #0000ff;"><a style="color: #0000ff;" href="../../../results.html">all 5 trials published in Annals</a></span> over the 6 week period misreported their prespecified outcomes, and so we sent a correction letter on each trial.</span></p>
<p><span style="color: #000000;">We also identified a systemic problem. None of these trials had a publicly accessible protocol dated before trial commencement, so we took the prespecified outcomes from the trial registry entries, and compared these against those published in the report. This is not necessarily a problem: trial registers were set up explicitly for the purpose of preventing selective reporting of outcomes, with support from august bodies such as ICMJE, WHO, and legislation across various territories.</span></p>
<p><span style="color: #000000;">In response, Annals’ editors claimed that the registry entries are often “<span style="color: #0000ff;"><a style="color: #0000ff;" href="http://annals.org/article.aspx?articleid=2478526">outdated, vague or erroneous</a></span>”, and that the discrepancies we found are accounted for by trial protocols that cannot be accessed publicly, but are reviewed by editors behind closed doors. We view this as a very outdated approach, lacking in transparency, and a problematic view of trial registers.</span> <a href="../../annals-update-protocol-sharing-requirements-for-trialists-after-compare-finds-shortcomings/index.html#more-599" class="more-link">[Read more&#8230;]</a></p>
</div><footer class="entry-footer"></footer></article><article class="post-592 post type-post status-publish format-standard category-uncategorized entry" itemscope itemtype="http://schema.org/CreativeWork"><header class="entry-header"><h1 class="entry-title" itemprop="headline"><a href="../../the-lancet-and-compare-why-journals-should-address-outcome-switching-themselves/index.html" rel="bookmark">The Lancet and COMPare: why journals should address outcome switching themselves</a></h1> 
<p class="entry-meta"><time class="entry-time" itemprop="datePublished" datetime="2016-04-29T08:01:15+00:00">April 29, 2016</time> - by <span class="entry-author" itemprop="author" itemscope itemtype="http://schema.org/Person"><a href="index.html" class="entry-author-link" itemprop="url" rel="author"><span class="entry-author-name" itemprop="name">Henry Drysdale</span></a></span> <span class="entry-comments-link"><a href="../../the-lancet-and-compare-why-journals-should-address-outcome-switching-themselves/index.html#comments">3 Comments</a></span></p></header><div class="entry-content" itemprop="text"><p><span style="color: #000000;"><span style="font-weight: 400;">As you will hopefully know by now, we have been writing to five leading medical journals to correct the record on misreported trials. We have sent 58 letters in total, and the responses have been varied: some (such as the </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../reeact-in-the-bmj-good-science-in-action/index.html"><span style="font-weight: 400;">BMJ</span></a></span><span style="font-weight: 400;">) have issued rapid corrections, whereas others (such as </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../jama-reject-all-correction-letters/index.html"><span style="font-weight: 400;">JAMA</span></a></span><span style="font-weight: 400;"> and </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../how-did-nejm-respond-when-we-tried-to-correct-20-misreported-trials/index.html"><span style="font-weight: 400;">NEJM</span></a></span><span style="font-weight: 400;">) have refused to publish any correspondence at all. The Lancet have taken a mixed approach: of 19 letters of correction we submitted they have so far published 8, accepted a further 3 for future publication, and rejected 2; with 6 still under editorial review dating back as far as 5 months.</span></span></p>
<p><span style="font-weight: 400; color: #000000;">However, there is an extra feature, around an important issue: who should take responsibility for misreported outcomes in clinical trials? We think journals have a clear set of roles and responsibilities here, not least because so many are listed as endorsing the CONSORT guidelines, which explicitly state that all prespecified outcomes should be reported. The Lancet have somewhat absented themselves from this discussion. Our published correction letters have, in most cases, been accompanied by letters from other researchers raising methodological criticisms of the trial in question. In all cases, our published letters have been accompanied by an author’s reply. Where this reply has reiterated significant misrepresentations or misunderstandings around pre-specification of outcomes, we have written a follow-up letter to the journal to point these out. However, each of these subsequent letters has been rejected by the Lancet editors; and our efforts to get the Lancet editors themselves to give a view, on misreported outcomes in their journal, have not yet had a reply. </span> <a href="../../the-lancet-and-compare-why-journals-should-address-outcome-switching-themselves/index.html#more-592" class="more-link">[Read more&#8230;]</a></p>
</div><footer class="entry-footer"></footer></article><article class="post-462 post type-post status-publish format-standard category-uncategorized tag-jama entry" itemscope itemtype="http://schema.org/CreativeWork"><header class="entry-header"><h1 class="entry-title" itemprop="headline"><a href="../../jama-reject-all-correction-letters/index.html" rel="bookmark">JAMA reject correction letters on all trials they have misreported</a></h1> 
<p class="entry-meta"><time class="entry-time" itemprop="datePublished" datetime="2016-03-24T16:25:08+00:00">March 24, 2016</time> - by <span class="entry-author" itemprop="author" itemscope itemtype="http://schema.org/Person"><a href="index.html" class="entry-author-link" itemprop="url" rel="author"><span class="entry-author-name" itemprop="name">Henry Drysdale</span></a></span> <span class="entry-comments-link"><a href="../../jama-reject-all-correction-letters/index.html#comments">1 Comment</a></span></p></header><div class="entry-content" itemprop="text"><h4><span style="font-weight: 400; color: #000000;">Here we publish some correspondence with JAMA, who have declined to correct the record on a series of trials that they have misreported in their pages. </span></h4>
<h4><span style="color: #000000;"><span style="font-weight: 400;">First, one paragraph of background, for those unfamiliar with the problem of outcome switching, and COMPare’s efforts to address it. It is well established that academic journals </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../are-your-results-unusual-or-how-often-are-outcomes-switched/index.html"><span style="font-weight: 400;">routinely permit outcome switching</span></a></span><span style="font-weight: 400;"> in the trial reports that they publish, despite public commitments to address this problem. This is widely recognised as bad, for reasons we </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../are-your-results-unusual-or-how-often-are-outcomes-switched/index.html"><span style="font-weight: 400;">have already outlined</span></a></span><span style="font-weight: 400;">. For six weeks from October 2015, the </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../../team.html"><span style="font-weight: 400;">COMPare team</span></a></span><span style="font-weight: 400;"> analysed every RCT published in the top 5 medical journals to check if they had correctly reported their pre-specified outcomes. Where we found discrepancies between the outcomes that were pre-specified and those reported, we wrote a letter to that journal to correct the record. Our intention was to test whether the structures of science are working as they should, and specifically to see whether academic journals are transparent and self-correcting in the face of legitimate concerns being raised about misreporting of trial results. The responses we have received from journals have been extremely varied: from full public engagement and transparent corrections </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../reeact-in-the-bmj-good-science-in-action/index.html"><span style="font-weight: 400;">in the BMJ</span></a></span><span style="font-weight: 400;">, to inaccurate and concerning responses from the </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../where-does-annals-of-internal-medicine-stand-on-outcome-switching-a-detailed-response/index.html"><span style="font-weight: 400;">Annals of Internal Medicine</span></a></span> <a style="color: #000000;" href="../../where-does-annals-of-internal-medicine-stand-on-outcome-switching-a-detailed-response/index.html"><span style="font-weight: 400;">and the </span></a><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../how-did-nejm-respond-when-we-tried-to-correct-20-misreported-trials/index.html#more-330"><span style="font-weight: 400;">New England Journal of Medicine</span></a></span><span style="font-weight: 400;">.</span></span></h4>
<h4><span style="color: #000000;"><span style="font-weight: 400;">JAMA is a very widely read journal, with an impact factor of around 35. So far we have analysed 13 of their trials. Of 22 primary outcomes pre-specified across these papers, 17 were correctly reported. However, we also found 87 additional outcomes reported that were not pre-specified in the protocol or trial registry, and only 34 of these were declared as novel. Furthermore, 70 of the 105 pre-specified secondary outcomes spread across these publications were never reported. Our full results and raw data are available </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../../results.html"><span style="font-weight: 400;">here</span></a></span><span style="font-weight: 400;">. Only 2 of the trials we assessed from JAMA were perfectly reported. </span></span></h4>
<p> <a href="../../jama-reject-all-correction-letters/index.html#more-462" class="more-link">[Read more&#8230;]</a></p>
</div><footer class="entry-footer"><p class="entry-meta"><span class="entry-tags">Tagged With: <a href="../../tag/jama/index.html" rel="tag">jama</a></span></p></footer></article><article class="post-330 post type-post status-publish format-standard category-uncategorized tag-nejm entry" itemscope itemtype="http://schema.org/CreativeWork"><header class="entry-header"><h1 class="entry-title" itemprop="headline"><a href="../../how-did-nejm-respond-when-we-tried-to-correct-20-misreported-trials/index.html" rel="bookmark">How did NEJM respond when we tried to correct 20 misreported trials?</a></h1> 
<p class="entry-meta"><time class="entry-time" itemprop="datePublished" datetime="2016-02-25T14:13:49+00:00">February 25, 2016</time> - by <span class="entry-author" itemprop="author" itemscope itemtype="http://schema.org/Person"><a href="index.html" class="entry-author-link" itemprop="url" rel="author"><span class="entry-author-name" itemprop="name">Henry Drysdale</span></a></span> <span class="entry-comments-link"><a href="../../how-did-nejm-respond-when-we-tried-to-correct-20-misreported-trials/index.html#comments">14 Comments</a></span></p></header><div class="entry-content" itemprop="text"><h4><b></b><span style="color: #000000;"><span style="font-weight: 400;">It is well established that academic journals </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../are-your-results-unusual-or-how-often-are-outcomes-switched/index.html"><span style="font-weight: 400;">routinely permit outcome switching</span></a></span><span style="font-weight: 400;"> in the trial reports that they publish, despite public commitments to address this problem. For six weeks from October 2015, the </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../../index.html"><span style="font-weight: 400;">COMPare team</span></a></span><span style="font-weight: 400;"> analysed every RCT published in the top 5 medical journals to check if they had correctly reported their pre-specified outcomes. Where we found discrepancies between the outcomes that were pre-specified and those reported, we wrote a letter to that journal to correct the record. The responses we have received from journals have been extremely varied: from full public engagement and transparent corrections </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../reeact-in-the-bmj-good-science-in-action/index.html"><span style="font-weight: 400;">in the BMJ</span></a></span><span style="font-weight: 400;">, to inaccurate and concerning responses in the </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../where-does-annals-of-internal-medicine-stand-on-outcome-switching-a-detailed-response/index.html"><span style="font-weight: 400;">Annals of Internal Medicine</span></a></span><span style="font-weight: 400;">. </span></span></h4>
<h4><span style="color: #000000;"><span style="font-weight: 400;">New England Journal of Medicine (NEJM) is the highest impact factor journal in medicine. So far we have analysed 23 of their trials. To NEJM’s credit, of 32 primary outcomes pre-specified across these papers, 31 were correctly reported. However, 16 publications added in a total of 65 additional outcomes that were not pre-specified in the protocol or trial registry, and only 2 of these were declared as novel. Furthermore, a total of 160 pre-specified secondary outcomes spread across these publications were either not reported, or were reported incorrectly. Our full results and raw data are available </span><span style="color: #0000ff;"><a style="color: #0000ff;" href="../../../results.html"><span style="font-weight: 400;">here</span></a></span><span style="font-weight: 400;">. Only 3 trials were perfectly reported.</span></span></h4>
<p><span style="color: #000000;"> <a href="../../how-did-nejm-respond-when-we-tried-to-correct-20-misreported-trials/index.html#more-330" class="more-link">[Read more&#8230;]</a></span></p>
</div><footer class="entry-footer"><p class="entry-meta"><span class="entry-tags">Tagged With: <a href="../../tag/nejm/index.html" rel="tag">nejm</a></span></p></footer></article><article class="post-268 post type-post status-publish format-standard category-uncategorized tag-annals entry" itemscope itemtype="http://schema.org/CreativeWork"><header class="entry-header"><h1 class="entry-title" itemprop="headline"><a href="../../post-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making/index.html" rel="bookmark">Post-hoc “pre-specification” and undeclared deferral of results: a broken record in the making</a></h1> 
<p class="entry-meta"><time class="entry-time" itemprop="datePublished" datetime="2016-01-29T15:28:19+00:00">January 29, 2016</time> - by <span class="entry-author" itemprop="author" itemscope itemtype="http://schema.org/Person"><a href="index.html" class="entry-author-link" itemprop="url" rel="author"><span class="entry-author-name" itemprop="name">Henry Drysdale</span></a></span> <span class="entry-comments-link"><a href="../../post-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making/index.html#comments">1 Comment</a></span></p></header><div class="entry-content" itemprop="text"><h4><span style="font-weight: 400; color: #000000;">COMPare aims to fix the prevalent and ongoing problem of outcome switching in clinical trials. In short, outcome switching is when trialists report something different to what they originally said they were going to: it increases the risk of false positive results and exaggerated findings, and is therefore a bad thing. </span></h4>
<p><span style="font-weight: 400;"><span style="color: #000000;">For 6 weeks we assessed every trial published in the top 5 medical journals for discrepancies between pre-specified and reported outcomes. Of 67 trials, we found that 58 (87%) contain</span> </span><a href="../../../results.html"><span style="font-weight: 400;">misreported outcomes</span></a><span style="font-weight: 400; color: #000000;"> [1]. </span></p>
<p><span style="font-weight: 400;"><span style="color: #000000;">That was phase 1 of COMPare. We are now in phase 2: blogging on our findings and engaging the journals and authors in </span>public<span style="color: #000000;"> discussion on our specific assessments and their attitudes and policies on outcome reporting. The range of responses this has generated has been fascinating and enlightening; from</span> </span><a href="../../reeact-in-the-bmj-good-science-in-action/index.html"><span style="font-weight: 400;">best practice demonstrated by the BMJ </span></a><span style="font-weight: 400;"><span style="color: #000000;">[2], to extremely</span> </span><a href="../../where-does-annals-of-internal-medicine-stand-on-outcome-switching-a-detailed-response/index.html"><span style="font-weight: 400;">concerning views</span></a><span style="font-weight: 400; color: #000000;"> expressed and actions taken by Annals of Internal Medicine [3]. We are beginning to see a set of recurring themes in these responses that shed light on the underlying reasons for this prevalent problem; largely based on a fundamental misunderstanding of the importance of pre-specification and correct reporting of outcomes.</span></p>
<p> <a href="../../post-hoc-pre-specification-and-undeclared-separation-of-results-a-broken-record-in-the-making/index.html#more-268" class="more-link">[Read more&#8230;]</a></p>
</div><footer class="entry-footer"><p class="entry-meta"><span class="entry-tags">Tagged With: <a href="../../tag/annals/index.html" rel="tag">annals</a></span></p></footer></article><div class="archive-pagination pagination"><ul><li class="active"  aria-label="Current page"><a href="index.html">1</a></li>
<li><a href="page/2/index.html">2</a></li>
<li class="pagination-next"><a href="page/2/index.html" >Next Page &#x000BB;</a></li>
</ul></div>
</main></div></div><div class="footer-widgets"><div class="wrap"><div class="footer-widgets-1 widget-area"><section id="text-2" class="widget widget_text"><div class="widget-wrap"><h4 class="widget-title widgettitle">How to cite us</h4>
			<div class="textwidget"><p>Prior to publication of the first paper on COMPare, please cite this project as:</p>
<p><em>The COMPare Trials Project.</em> Goldacre B, Drysdale H, Powell-Smith A, et al. www.COMPare-trials.org, 2016.</p>
<p>Or alternatively:</p>
<p><em>The COMPare Trials Project.</em> Ben Goldacre, Henry Drysdale, Anna Powell-Smith, Aaron Dale, Ioan Milosevic, Eirion Slade, Philip Hartley, Cicely Marston, Kamal Mahtani, Carl Heneghan. www.COMPare-trials.org, 2016.</p>
</div>
		</div></section>
</div></div></div><footer class="site-footer" itemscope itemtype="http://schema.org/WPFooter"><div class="wrap"><span class="logos">
<a href="http://www.ox.ac.uk"><img src="../../../wp-content/uploads/2016/01/oxford_logo.png" alt="University of Oxford logo" height='40'/></a>
<a href="http://www.phc.ox.ac.uk"><img src="../../../wp-content/uploads/2016/01/nuffield_logo.png" alt="Nuffield Department of Primary Care Health Sciences logo" height='40'/></a>
<a href="http://www.cebm.net/"><img src="../../../wp-content/uploads/2016/01/cebm_logo.png" alt="Centre for Evidence-Based Medicine logo" height='40'/></a>
</span>

<p>
Copyright &#x000A9;&nbsp;2019 &middot; <a href="https://ebmdatalab.net">EBM Data Lab</a>
</p></div></footer></div><script type="text/javascript" src="https://cdn.datatables.net/s/dt/dt-1.10.10,fh-3.1.0,r-2.0.0/datatables.min.js"></script>
<script src="../../../wp-content/uploads/2016/01/tabletop.js"></script>
<script src="../../../wp-content/uploads/2016/01/countUp.js"></script>
<script src="../../../wp-content/uploads/2016/01/all.js"></script><script type='text/javascript' src='../../../wp-content/plugins/wp-show-more/wpsm-script.js%3Fver=1.0.1'></script>
<script type='text/javascript' src='../../../wp-content/plugins/easy-twitter-feed-widget/lib/js/widget-easy-twitter-feed-widget.js%3Fver=1.0'></script>
<script type='text/javascript' src='../../../wp-includes/js/wp-embed.min.js%3Fver=4.6.16'></script>
</body></html>
